Cargando…

Myostatin/Activin-A Signaling in the Vessel Wall and Vascular Calcification

A current hypothesis is that transforming growth factor-β signaling ligands, such as activin-A and myostatin, play a role in vascular damage in atherosclerosis and chronic kidney disease (CKD). Myostatin and activin-A bind with different affinity the activin receptors (type I or II), activating dist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito, Pasquale, Verzola, Daniela, Picciotto, Daniela, Cipriani, Leda, Viazzi, Francesca, Garibotto, Giacomo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393536/ https://www.ncbi.nlm.nih.gov/pubmed/34440838 http://dx.doi.org/10.3390/cells10082070

Ejemplares similares

Activin/myostatin receptor signaling and vascular calcifications in chronic kidney disease: A “liaison dangereuse”?
por: Garibotto, Giacomo, et al.
Publicado: (2019)

Enhanced myostatin expression and signalling promote tubulointerstitial inflammation in diabetic nephropathy
por: Verzola, Daniela, et al.
Publicado: (2020)

Role of Uric Acid in Vascular Remodeling: Cytoskeleton Changes and Migration in VSMCs
por: Russo, Elisa, et al.
Publicado: (2023)

Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease
por: Esposito, Pasquale, et al.
Publicado: (2020)

Homocysteine exchange across skeletal muscle in patients with chronic kidney disease
por: Garibotto, Giacomo, et al.
Publicado: (2023)

New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease
por: Esposito, Pasquale, et al.
Publicado: (2020)

How to Overcome Anabolic Resistance in Dialysis-Treated Patients?
por: Garibotto, Giacomo, et al.
Publicado: (2021)

Low Protein Diets and Plant-Based Low Protein Diets: Do They Meet Protein Requirements of Patients with Chronic Kidney Disease?
por: Verzola, Daniela, et al.
Publicado: (2020)

The Contribution of Muscle Innate Immunity to Uremic Cachexia
por: Esposito, Pasquale, et al.
Publicado: (2023)

Effects of Different Dialysis Strategies on Inflammatory Cytokine Profile in Maintenance Hemodialysis Patients with COVID-19: A Randomized Trial
por: Esposito, Pasquale, et al.
Publicado: (2021)

Nutritional Challenges in Pregnant Women with Renal Diseases: Relevance to Fetal Outcomes
por: Esposito, Pasquale, et al.
Publicado: (2020)

Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities
por: Esposito, Pasquale, et al.
Publicado: (2017)

Treatment of Chronic Kidney Disease: Moving Forward
por: Garibotto, Giacomo, et al.
Publicado: (2022)

Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4
por: Verzola, Daniela, et al.
Publicado: (2014)

Renal Ischemia/Reperfusion Early Induces Myostatin and PCSK9 Expression in Rat Kidneys and HK-2 Cells
por: Barisione, Chiara, et al.
Publicado: (2021)

Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis
por: Garibotto, Giacomo, et al.
Publicado: (2015)

Kidney Transplantation in a Patient Affected by Sickle Cell Trait: A Case Report and State-of-the-Art Review
por: Picciotto, Daniela, et al.
Publicado: (2023)

Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet
por: Russo, Elisa, et al.
Publicado: (2021)

Compression of morbidity in a progeroid mouse model through the attenuation of myostatin/activin signalling
por: Alyodawi, Khalid, et al.
Publicado: (2019)

Toll‐like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease
por: Verzola, Daniela, et al.
Publicado: (2016)

Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall
por: Dube, Prabhatchandra, et al.
Publicado: (2021)

Vessel wall calcification and vascular event: Are we concerned enough?
por: Chakraborty, Debabrata, et al.
Publicado: (2022)

Indoxyl Sulfate Induces Renal Fibroblast Activation through a Targetable Heat Shock Protein 90-Dependent Pathway
por: Milanesi, Samantha, et al.
Publicado: (2019)

Effects of Low-Protein, and Supplemented Very Low–Protein Diets, on Muscle Protein Turnover in Patients With CKD
por: Garibotto, Giacomo, et al.
Publicado: (2018)

Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment
por: Verzola, D., et al.
Publicado: (2017)

Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age
por: Russo, Elisa, et al.
Publicado: (2020)

Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes
por: Esposito, Pasquale, et al.
Publicado: (2023)

Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
por: Rodgers, Buel D, et al.
Publicado: (2021)

Inhibition of Activin/Myostatin signalling induces skeletal muscle hypertrophy but impairs mouse testicular development
por: Vaughan, Danielle, et al.
Publicado: (2020)

Changes of Acute Kidney Injury Epidemiology during the COVID-19 Pandemic: A Retrospective Cohort Study
por: Esposito, Pasquale, et al.
Publicado: (2022)

Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components
por: Russo, Elisa, et al.
Publicado: (2023)

Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone
por: Iskenderian, Andrea, et al.
Publicado: (2018)

A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities
por: Vaughan, Danielle, et al.
Publicado: (2021)

Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk
por: Wu, Jiao, et al.
Publicado: (2019)

Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight
por: Lee, Se-Jin, et al.
Publicado: (2020)

Whole‐Body Metabolism and the Musculoskeletal Impacts of Targeting Activin A and Myostatin in Severe Osteogenesis Imperfecta
por: Omosule, Catherine L., et al.
Publicado: (2023)

Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review
por: Esposito, Pasquale, et al.
Publicado: (2023)

Protein-Energy Wasting and Mortality in Chronic Kidney Disease
por: Bonanni, Alice, et al.
Publicado: (2011)

Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A
por: Lee, Se-Jin, et al.
Publicado: (2020)

The Evolving Scenario of COVID-19 in Hemodialysis Patients
por: Esposito, Pasquale, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9s2uc5dsd4bkncq4j7mfrs9l5v